Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study. (Q51186202)

1 April 2018

title

Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study. (English)

1 reference

1 April 2018

1 reference

1

1 reference

1 April 2018

Matthias Cavassini

object named as

Matthias Cavassini

7

0 references

Manuel Battegay

9

object named as

Manuel Battegay

1 reference

PubMed ID

17507323

1 April 2018

Swiss HIV Cohort Study

11

object named as

Swiss HIV Cohort Study

1 reference

1 April 2018

6

Enos Bernasconi

1 reference

1 April 2018

8

Bernard Hirschel

1 reference

1 April 2018

5

Hansjakob Furrer

1 reference

1 April 2018

author name string

Rainer Weber

2

1 reference

1 April 2018

Pietro L Vernazza

3

1 reference

1 April 2018

Martin Rickenbach

4

1 reference

1 April 2018

Heiner C Bucher

10

1 reference

1 April 2018

publication date

1 March 2007

1 reference

1 April 2018

published in

HIV Clinical Trials

1 reference

1 April 2018

volume

8

1 reference

1 April 2018

issue

2

1 reference

1 April 2018

page(s)

77-85

1 reference

1 April 2018

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

cites work

1 reference

https://api.crossref.org/works/10.1310%2FHCT0802-77

Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0802-77

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0802-77

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0802-77

Increased use of lipid-lowering therapy in patients receiving human immunodeficiency virus protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0802-77

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0802-77

Therapeutic goal attainment in patients with hypertension and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0802-77

Effect of different antilipidemic agents and diets on mortality: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0802-77

Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0802-77

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0802-77

Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0802-77

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0802-77

Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0802-77

21 January 2018

Identifiers

DOI

10.1310/HCT0802-77

1 reference

1 April 2018

PubMed ID

17507323

1 reference

1 April 2018